DI IOIA, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.141
EU - Europa 1.491
AS - Asia 1.148
SA - Sud America 134
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 4.937
Nazione #
US - Stati Uniti d'America 2.103
CN - Cina 443
SG - Singapore 379
DE - Germania 237
IE - Irlanda 225
IT - Italia 212
UA - Ucraina 180
GB - Regno Unito 164
TR - Turchia 156
SE - Svezia 146
BR - Brasile 120
FI - Finlandia 111
FR - Francia 104
IN - India 59
VN - Vietnam 46
CA - Canada 32
RU - Federazione Russa 32
CZ - Repubblica Ceca 18
BE - Belgio 12
PL - Polonia 12
JP - Giappone 10
HK - Hong Kong 8
ZA - Sudafrica 8
BD - Bangladesh 7
CH - Svizzera 7
ES - Italia 7
EU - Europa 7
MX - Messico 6
AU - Australia 5
NL - Olanda 5
PK - Pakistan 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
IR - Iran 4
SA - Arabia Saudita 4
ID - Indonesia 3
KR - Corea 3
AT - Austria 2
DK - Danimarca 2
GR - Grecia 2
IQ - Iraq 2
KZ - Kazakistan 2
MY - Malesia 2
NP - Nepal 2
PH - Filippine 2
PY - Paraguay 2
RO - Romania 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BW - Botswana 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
PE - Perù 1
SR - Suriname 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.937
Città #
Chandler 288
Singapore 275
Jacksonville 251
Dublin 222
Dallas 168
Beijing 140
Ashburn 139
Munich 139
Southend 116
Princeton 94
The Dalles 88
Nanjing 85
Ann Arbor 76
Izmir 73
Chieti 71
Dearborn 62
New York 56
Los Angeles 53
Helsinki 52
Santa Clara 43
Wilmington 40
Cambridge 39
Altamura 32
Nanchang 29
Tongling 27
Boardman 21
Ho Chi Minh City 18
Washington 18
Woodbridge 18
São Paulo 17
Turku 17
Redondo Beach 16
Grevenbroich 15
Montreal 15
Brno 14
Buffalo 14
Kunming 14
Frankfurt am Main 13
Shenyang 13
Brussels 12
Guangzhou 12
Jiaxing 12
Denver 11
Hebei 11
London 11
Norwalk 11
Tianjin 11
Tokyo 10
Atlanta 9
Hangzhou 9
Houston 9
Stockholm 9
Toronto 9
Warsaw 9
Hong Kong 8
San Francisco 8
San Mateo 8
Changsha 7
Hanoi 7
Monmouth Junction 7
Nuremberg 7
Orem 7
Phoenix 7
Brooklyn 6
Dong Ket 6
Falls Church 6
Fribourg 6
Jinan 6
Lanzhou 6
Poplar 6
Amsterdam 5
Belgrade 5
Camerino 5
Pescara 5
Roseto Degli Abruzzi 5
Seattle 5
Ankara 4
Boston 4
Changchun 4
Curitiba 4
Edinburgh 4
Hanover 4
Johannesburg 4
Manchester 4
Montesilvano Marina 4
Olomouc 4
Rome 4
San Vito Chietino 4
Teramo 4
Zhengzhou 4
Ardabil 3
Augusta 3
Chennai 3
Council Bluffs 3
Hefei 3
Hyderabad 3
La Spezia 3
Mexico City 3
Milan 3
Mumbai 3
Totale 3.260
Nome #
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 327
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 187
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 160
Cleavage of cystatin C is not associated with multiple sclerosis 147
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 146
Increasing age at disability milestones among MS patients in the MSBase Registry 137
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 134
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 130
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 130
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 128
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 124
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 118
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 118
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 116
Data of safety in a single-center alemtuzumab treated population 115
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 114
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 113
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 113
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 112
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 112
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 111
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 108
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 107
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 107
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 106
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 105
JCV-Ab serostatus in MS patients treated with Natalizumab 104
Nail loss after teriflunomide treatment: a new potential adverse event 100
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 98
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group 98
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 94
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 93
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 92
Natalizumab-associated PML-IRIS: the Chieti experience. 91
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 91
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 89
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 85
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 84
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 81
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 81
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients 76
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 74
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis 68
Lipidomics analysis reveals low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluido f multiple sclerosis patients. 66
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 62
Totale 5.052
Categoria #
all - tutte 19.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021167 0 0 0 0 0 52 5 0 41 25 30 14
2021/2022232 4 4 9 42 9 13 10 20 16 9 24 72
2022/2023757 61 109 43 74 93 133 34 54 104 15 24 13
2023/2024394 17 18 33 6 30 181 48 5 1 8 2 45
2024/2025979 50 103 110 11 23 63 94 52 103 44 164 162
2025/2026908 163 41 234 246 202 22 0 0 0 0 0 0
Totale 5.052